Tang, Chad <br/><br/>
Synergy between VEGF/VEGFR inhibitors and chemotherapy agents in the phase I clinic.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Dec 2014 
 - 5956-63 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-14-1582  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Child<br/>Child, Preschool<br/>Drug Synergism<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Mutation<br/>Neoplasms--diagnosis<br/>Odds Ratio<br/>Protein Kinase Inhibitors--administration & dosage<br/>Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Young Adult